Masaru Hikichi

Fujita Health University

Papers

3

Total Citations

38

H-Index

3

About

Dr. Masaru Hikichi is a leading urologic surgeon and researcher whose work centers on advancing robot-assisted surgery for kidney and prostate cancers. His primary contributions lie in optimizing surgical techniques for complex renal tumors and high-risk prostate cancer. In a landmark 2019 study, he identified key predictors for achieving the "trifecta" (negative margins, minimal complications, and preserved renal function) during robot-assisted partial nephrectomy for high-complexity tumors (Preoperative Aspects and Dimensions Used for an Anatomical score ≥10), a work cited 17 times. That same year, he published a pivotal analysis of nerve-sparing versus non-nerve-sparing robot-assisted radical prostatectomy in high-risk prostate cancer cases, demonstrating that nerve-sparing approaches can be safely employed without compromising oncological outcomes—a study with 16 citations that has influenced surgical decision-making. Dr. Hikichi was also among the early adopters of the da Vinci S™ surgical system for partial nephrectomy, reporting on his initial five cases in 2011 and helping to establish the feasibility of this minimally invasive approach for localized renal tumors. His cumulative work, with over 38 citations, continues to shape best practices in urologic oncology, balancing aggressive cancer control with quality-of-life preservation.

Research Focus

Key Achievements

3
H-Index
3
Papers
38
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Predictors for trifecta achievement of robot‐assisted partial nephrectomy in high‐complexity tumors (Preoperative Aspects and Dimensions Used for an Anatomical score ≥10)
17 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Fujita Health University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago